Dr. Mukund Seshadri will present their interdisciplinary research on developing and evaluating ultrasound and photoacoustic imaging for oral oncology applications, with a focus on the prognostic utility of these methods in assessing treatment responses in head and neck cancer patients.
VisualSonics presents the first episode of their Vevo 4 Photoacoustics Web Series - Combined near infrared photoacoustic imaging and ultrasound detects vulnerable atherosclerotic plaque with Martin Schneider, MD/PhD from Stanford University.
Given that Alzheimer's disease is multifactorial and heterogenous, drug development progress is more likely to occur if multiple pathways are considered. Two recent Nature publications have potentially identified medin and PLD3 as new targets for Alzheimer’s disease treatment, which we summarize in this mini-review.
Join Dr. Danyi Wen as she describes a novel drug efficacy test using Patient Derived Xenograft (PDX) samples to measure drug efficacy and identify therapeutic candidates in personalized oncology treatments.